Vassol Inc.

03/22/2016

The Chicago Tribune article about VasSol was picked up by the Atlanta Journal-Constitution and the Palm Beach Post Today.

CHICAGO — Software is helping doctors determine whether a patient could have another stroke.

03/14/2016

Dr. Shyam Prabhakaran talks about the value of NOVA in today's Chicago Tribune. And wouldn't everyone who had a stroke want to know their risk of a subsequent stroke?

A River Forest company's software is helping doctors determine whether a patient could have another stroke.

03/08/2016

NOVA was a huge hit at the International Stroke Conference in Los Angeles in February. Distinguished physicians were allotted almost 2 1/2 hours of time to discuss how a NOVA scan is necessary for almost ANY stroke patient to determine medical management options and interventional choices. Contact VasSol for information on the speeches.

03/08/2016

NO Gadolinium needed when working with NOVA. The N in NOVA stands for "Non-Invasive".

VIENNA - There's a serious risk of a phobia developing over the use of gadolinium-based MRI contrast agents, following the recent publication of a stinging attack on these agents in a German newspaper, ECR 2016 delegates were told at Friday's highly charged special focus session on brain hypersignal…

02/14/2016

For copies of the JAMA-Neurology article or the editorial setting a new standard of care for treatment of stroke patients, contact us directly. Contact information is available on the VasSol website.

NOVA is a flow analysis system that works with Time-of-Flight MRA and 2D phase-contrast magnetic resonance imaging to produce a 3D model of the vasculature and quantify vessel blood flow.

01/23/2016

The VERiTAS results were released in JAMA-Neurology. They editorialize that NOVA should immediately be used to make medical management decisions in posterior stroke patients.

River Forest, IL (PRWEB) January 13, 2016 -- VasSol™ Inc.'s NOVA® blood-flow measurement technology, which runs on MRI equipment, identified patients at higher risk of recurrent stroke in a recently completed clinical trial. JAMA Neurology published the results.

01/05/2016

The #6 Radiology Story of 2015 was the risk associated with gadolinium usage in radiology. VasSol's NOVA product proudly visualizes and measures blood flow without need for any contrast agent.

We're pleased to offer the top 10 stories on AuntMinnie.com for 2015, as measured by member traffic. Breast cancer screening, CT lung cancer screening, and the potential risks of gadolinium contrast were all hot topics this year.

12/21/2015

The incredible VERiTAS results that prove that the NOVA® software helps predict recurrent stroke were published in "JAMA-Neurology" today. The MSM is also picking up the excitement.

11/11/2015

CEO, Chuck Doherty talks VasSol in todays Daily Herald Business Ledger.

Q: How do you describe your business? A: By FDA standards, we are a medical device manufacturer, but we think of ourselves as producing software to improve str